Roche Holding AG (OTCQX International Premier:RHHBF)
| 299.71 Delayed Data As of Mar 24 |  -0.30 / -0.10%Today’s Change | 293.50 Today|||52-Week Range 466.14 | -23.05% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $32.0B |
Company Description
Roche Holding AG operates as a research healthcare company. It operates through the following divisions: Pharmaceuticals and Diagnostics. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Contact Information
Roche Holding AG Grenzacherstrasse 124 Basel Basel-stadt (basle Town) 4058 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Thomas Schinecker | Chief Executive Officer |
| Alan Hippe | Chief Financial & Information Officer |
| Levi A. Garraway | Chief Medical Officer |
| Pascale Schmidt | Chief Compliance Officer |
| Per-Olof Attinger | Secretary-Executive Committee & Head-CEO Office |
